AKT1 and thyroiditis: As the second most common genetic alteration in PTC, point mutations of the RAS gene result in the constitutive and aberrant activation of downstream MAPK and PI3K/AKT signaling pathways, which is a critical event in thyroid tumorigenesis [30, 31].